Emerging Frontiers curates intimate, off-the-record discussions that seek to address timely topics. We develop a thought-provoking theme each year that explores the core pillars of progress: Research (where breakthroughs begin), Innovation (how they are implemented), and People (the driving force behind it all). By fostering open, meaningful dialogue, we aim to unify stakeholders and drive forward-looking solutions for biotech’s most pressing challenges.
Through our fundraising efforts, we’ve supported organizations like Damon Runyon, Parker Institute for Cancer Immunotherapy, Fred Hutch Cancer Center, and Life Science Cares.
Our 2025 summit will examine the evolving dynamics of oncology investment, featuring insights from foundations, investors, biopharma, entrepreneurs, and researchers. Discussions will focus on shaping the future innovation funnel, optimizing investment strategies, and leveraging talent to create lasting impact.
Company Details
- Founded
- -
- Address
- Boston, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- IT Consulting.
- HQ
- Boston
Emerging Frontiers In Oncology Questions
Emerging Frontiers In Oncology's website is https://emergingfrontiersoncology.com
Emerging Frontiers In Oncology's LinkedIn profile is https://www.linkedin.com/company/emerging-frontiers-in-oncology
Emerging Frontiers In Oncology's industry is
Biotechnology Research
Emerging Frontiers In Oncology's top competitors are
Angio8,
Exigyn,
Cold Start Therapeutics,
Seal Rock Therapeutics,
Avalon Decisions Inc.,
Carve Bio,
Greenberg Traurig, Llp,
Massbio,
Solitek - Solid Technologies Sl,
Welch Center For Prevention, Epidemiology, And Clinical Research.
Emerging Frontiers In Oncology's categories are Biotechnology Research
Emerging Frontiers In Oncology's founding year is 2019
